RecruitingNCT07052604

Antibiotic Treatment for Pneumonia Caused by Stenotrophomonas Maltophilia in ICU Patients


Sponsor

Centre Hospitalier de Saint-Denis

Enrollment

300 participants

Start Date

Dec 15, 2023

Study Type

OBSERVATIONAL

Conditions

Summary

This study looks at how different antibiotic treatments affect patients in intensive care who have pneumonia caused by the bacteria Stenotrophomonas maltophilia. It compares using one antibiotic versus two antibiotics, and treatment lengths of 7 days versus 14 days, to see which approach helps patients survive better. The study also examines how resistant the bacteria are to antibiotics and how often the pneumonia comes back.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a new treatment for people with anti-bacterial agents, drug resistance, bacterial, and other related conditions. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

Centre Hospitalier de Saint-Denis

Saint-Denis, France, France

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07052604


Related Trials